Abbott Laboratories closed 10.57% short of its 52-week high of $141.23, which the company reached on March 4th.

We recently published a list of 10 Best Diabetes Stocks To Buy According to Billionaires. In this article, we are going to ...

Abbott Laboratories ABT has witnessed strong momentum in the past year. Shares of the company have risen 12.7% compared with the 9% growth of the industry during the same time frame. The S&P 500 ...

Today, Benzinga 's options scanner spotted 10 uncommon options trades for Abbott Laboratories. This isn't normal. The overall ...

Abbott Laboratories' medical device business is executing well, with double-digit growth in structural heart and diabetes.

The decision to allow a new trial could have  implications for both the companies and families with babies born prematurely.

The test is expected to help rule out the need for CT scans in evaluating potential brain tissue damage caused by concussions ...

We recently published a list of Friday’s 10 Worst Performing Stocks. In this article, we are going to take a look at where ...

Abbott Laboratories and Reckitt Benckiser Group Plc shares fell as a judge ordered a new trial after rejecting a verdict that ...

Bearish flow noted in Abbott (ABT) with 3,285 puts trading, or 2x expected. Most active are Mar-25 126 puts and Mar-25 127 puts, with total ...

Abbott Laboratories closed 2.90% short of its 52-week high of $141.23, which the company achieved on March 4th.